_version_ 1783524578025275392
author Shaker, Marcus S.
Oppenheimer, John
Grayson, Mitchell
Stukus, David
Hartog, Nicholas
Hsieh, Elena W.Y.
Rider, Nicholas
Dutmer, Cullen M.
Vander Leek, Timothy K.
Kim, Harold
Chan, Edmond S.
Mack, Doug
Ellis, Anne K.
Lang, David
Lieberman, Jay
Fleischer, David
Golden, David B.K.
Wallace, Dana
Portnoy, Jay
Mosnaim, Giselle
Greenhawt, Matthew
author_facet Shaker, Marcus S.
Oppenheimer, John
Grayson, Mitchell
Stukus, David
Hartog, Nicholas
Hsieh, Elena W.Y.
Rider, Nicholas
Dutmer, Cullen M.
Vander Leek, Timothy K.
Kim, Harold
Chan, Edmond S.
Mack, Doug
Ellis, Anne K.
Lang, David
Lieberman, Jay
Fleischer, David
Golden, David B.K.
Wallace, Dana
Portnoy, Jay
Mosnaim, Giselle
Greenhawt, Matthew
author_sort Shaker, Marcus S.
collection PubMed
description
format Online
Article
Text
id pubmed-7174169
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Academy of Allergy, Asthma & Immunology
record_format MEDLINE/PubMed
spelling pubmed-71741692020-04-22 Reply to “Subcutaneous terbutaline as an alternative to aerosolized albuterol” Shaker, Marcus S. Oppenheimer, John Grayson, Mitchell Stukus, David Hartog, Nicholas Hsieh, Elena W.Y. Rider, Nicholas Dutmer, Cullen M. Vander Leek, Timothy K. Kim, Harold Chan, Edmond S. Mack, Doug Ellis, Anne K. Lang, David Lieberman, Jay Fleischer, David Golden, David B.K. Wallace, Dana Portnoy, Jay Mosnaim, Giselle Greenhawt, Matthew J Allergy Clin Immunol Pract Article American Academy of Allergy, Asthma & Immunology 2020 2020-04-22 /pmc/articles/PMC7174169/ /pubmed/32340824 http://dx.doi.org/10.1016/j.jaip.2020.04.016 Text en © 2020 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Shaker, Marcus S.
Oppenheimer, John
Grayson, Mitchell
Stukus, David
Hartog, Nicholas
Hsieh, Elena W.Y.
Rider, Nicholas
Dutmer, Cullen M.
Vander Leek, Timothy K.
Kim, Harold
Chan, Edmond S.
Mack, Doug
Ellis, Anne K.
Lang, David
Lieberman, Jay
Fleischer, David
Golden, David B.K.
Wallace, Dana
Portnoy, Jay
Mosnaim, Giselle
Greenhawt, Matthew
Reply to “Subcutaneous terbutaline as an alternative to aerosolized albuterol”
title Reply to “Subcutaneous terbutaline as an alternative to aerosolized albuterol”
title_full Reply to “Subcutaneous terbutaline as an alternative to aerosolized albuterol”
title_fullStr Reply to “Subcutaneous terbutaline as an alternative to aerosolized albuterol”
title_full_unstemmed Reply to “Subcutaneous terbutaline as an alternative to aerosolized albuterol”
title_short Reply to “Subcutaneous terbutaline as an alternative to aerosolized albuterol”
title_sort reply to “subcutaneous terbutaline as an alternative to aerosolized albuterol”
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174169/
https://www.ncbi.nlm.nih.gov/pubmed/32340824
http://dx.doi.org/10.1016/j.jaip.2020.04.016
work_keys_str_mv AT shakermarcuss replytosubcutaneousterbutalineasanalternativetoaerosolizedalbuterol
AT oppenheimerjohn replytosubcutaneousterbutalineasanalternativetoaerosolizedalbuterol
AT graysonmitchell replytosubcutaneousterbutalineasanalternativetoaerosolizedalbuterol
AT stukusdavid replytosubcutaneousterbutalineasanalternativetoaerosolizedalbuterol
AT hartognicholas replytosubcutaneousterbutalineasanalternativetoaerosolizedalbuterol
AT hsiehelenawy replytosubcutaneousterbutalineasanalternativetoaerosolizedalbuterol
AT ridernicholas replytosubcutaneousterbutalineasanalternativetoaerosolizedalbuterol
AT dutmercullenm replytosubcutaneousterbutalineasanalternativetoaerosolizedalbuterol
AT vanderleektimothyk replytosubcutaneousterbutalineasanalternativetoaerosolizedalbuterol
AT kimharold replytosubcutaneousterbutalineasanalternativetoaerosolizedalbuterol
AT chanedmonds replytosubcutaneousterbutalineasanalternativetoaerosolizedalbuterol
AT mackdoug replytosubcutaneousterbutalineasanalternativetoaerosolizedalbuterol
AT ellisannek replytosubcutaneousterbutalineasanalternativetoaerosolizedalbuterol
AT langdavid replytosubcutaneousterbutalineasanalternativetoaerosolizedalbuterol
AT liebermanjay replytosubcutaneousterbutalineasanalternativetoaerosolizedalbuterol
AT fleischerdavid replytosubcutaneousterbutalineasanalternativetoaerosolizedalbuterol
AT goldendavidbk replytosubcutaneousterbutalineasanalternativetoaerosolizedalbuterol
AT wallacedana replytosubcutaneousterbutalineasanalternativetoaerosolizedalbuterol
AT portnoyjay replytosubcutaneousterbutalineasanalternativetoaerosolizedalbuterol
AT mosnaimgiselle replytosubcutaneousterbutalineasanalternativetoaerosolizedalbuterol
AT greenhawtmatthew replytosubcutaneousterbutalineasanalternativetoaerosolizedalbuterol